{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:02:02Z","timestamp":1768413722727,"version":"3.49.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1097\/rlu.0000000000001760","type":"journal-article","created":{"date-parts":[[2017,7,22]],"date-time":"2017-07-22T22:37:37Z","timestamp":1500763057000},"page":"692-694","source":"Crossref","is-referenced-by-count":11,"title":["Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome Combined With Adrenocortical Carcinoma on 18F-FDG PET\/CT"],"prefix":"10.1097","volume":"42","author":[{"given":"Xiuyu","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210204","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pharmthera.2009.03.013","article-title":"New targets and therapeutic approaches for endocrine malignancies","volume":"123","author":"Fassnacht","year":"2009","journal-title":"Pharmacol Ther"},{"key":"R2-10-20210204","first-page":"103","article-title":"Adrenal lymphoma: presentation, management and prognosis","volume":"110","author":"Laurent","year":"2017","journal-title":"QJM"},{"key":"R3-10-20210204","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1677\/ERC-07-0074","article-title":"The diagnosis and management of malignant phaeochromocytoma and paraganglioma","volume":"14","author":"Chrisoulidou","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"R4-10-20210204","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.lpm.2014.01.009","article-title":"Adrenocortical carcinoma: update in 2014 [in French]","volume":"43","author":"Lib\u00e9","year":"2014","journal-title":"Presse Med"},{"key":"R5-10-20210204","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11255-016-1460-3","article-title":"Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade","volume":"49","author":"Mytsyk","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"R6-10-20210204","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12672-011-0089-z","article-title":"Conventional imaging in adrenocortical carcinoma: update and perspectives","volume":"2","author":"Young","year":"2011","journal-title":"Horm Cancer"},{"key":"R7-10-20210204","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s00259-014-2834-3","article-title":"Impact of 18F-FDG PET\/CT on the management of adrenocortical carcinoma: analysis of 106 patients","volume":"41","author":"Takeuchi","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R8-10-20210204","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1148\/radiol.2383042164","article-title":"Adrenal lesions: characterization with fused PET\/CT image in patients with proved or suspected malignancy\u2014initial experience","volume":"238","author":"Blake","year":"2006","journal-title":"Radiology"},{"key":"R9-10-20210204","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1148\/radiol.2015132798","article-title":"Case 221: hereditary leiomyomatosis and renal cell cancer syndrome","volume":"276","author":"van der Pol","year":"2015","journal-title":"Radiology"},{"key":"R10-10-20210204","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00268-011-1374-2","article-title":"Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors","volume":"36","author":"Gust","year":"2012","journal-title":"World J Surg"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000001760","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:19:39Z","timestamp":1620973179000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201709000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001760","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}